Home » GlaxoSmithKline Won’t Swallow Human Genome Sciences’ Poison Pill
GlaxoSmithKline Won’t Swallow Human Genome Sciences’ Poison Pill
GlaxoSmithKline said Wednesday that Human Genome Sciences will need to drop a “poison pill” provision for the takeover of the Rockville biotech to move forward.
Washington Business Journal
Washington Business Journal
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May